Breakthrough technology from LifeNet Health revolutionizes the delivery of allografts in minimally invasive surgeries, optimizing patient outcomes in surgery

2023 Rose Parade floragraph to commemorate Brittany Hoover’s final act of generosity

Virginia Beach, Va. (Dec 27, 2022) — Brittany Hoover, a Virginia woman who became an organ donor after her death earlier this year, will be featured on the Donate Life float in the Rose Parade in Pasadena, Calif., on Jan. 2.

A study published in

The exhibit features ViviGen^® MIS, the first viable cellular allograft delivery system designed specifically for minimally invasive surgery

Exhibit features live presentations and interactive content highlighting innovative allograft biologics for bone healing and joint reconstruction

Virginia Beach, Va. (Dec. 29, 2021) — Tyler Spann, a teenager who became a tissue donor after his death in 2018, will represent LifeNet Health on the 2022 Donate Life float in the New Year’s Day Rose Parade. Additionally, Kim McMahon, a tissue recipient, has been selected to ride on the float on Jan. 1.

Virginia Beach, Va. (Dec. 7, 2021) — LifeNet Health, a world leader in biologic surgical solutions, has added real-time location-tracking technology to its OsteoCleanse® autograft cleaning and storage service, bringing a new level of certainty to hospitals and patients.

Boston, Mass. (Sept. 28, 2021) — LifeNet Health, the world leader in allograft biologics, has optimized its industry-leading cellular bone matrix for minimally invasive surgery with the launch of ViviGen^® MIS Delivery System, a major improvement in precision, efficiency and reliability over traditional bone-graft delivery.

San Diego, Calif. (Aug. 31, 2021) — LifeNet Health, the world’s leading provider of allograft biologics, is showcasing its comprehensive portfolio of advanced biomaterials at the 2021 AAOS Annual Meeting (Booth #1527) Sept. 1-3.

Recent peer-reviewed publications continue to demonstrate the clinical advantage of ViviGen’s
lineage-committed, viable bone cells in high-risk foot and ankle procedures